Verona Pharma PLC American Depositary Share (VRNA) Competitors

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) and BeOne Medicines (NASDAQ:ONC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

Does the media refer more to VRNA or ONC?

In the previous week, BeOne Medicines had 10 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 13 mentions for BeOne Medicines and 3 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.34 beat BeOne Medicines' score of 0.47 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Verona Pharma PLC American Depositary Share	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BeOne Medicines	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is VRNA or ONC more profitable?

Verona Pharma PLC American Depositary Share has a net margin of 0.00% compared to BeOne Medicines' net margin of -9.40%. BeOne Medicines' return on equity of -7.55% beat Verona Pharma PLC American Depositary Share's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verona Pharma PLC American Depositary Share	N/A	-69.65%	-28.00%
BeOne Medicines	-9.40%	-7.55%	-4.42%

Which has stronger earnings & valuation, VRNA or ONC?

Verona Pharma PLC American Depositary Share has higher earnings, but lower revenue than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verona Pharma PLC American Depositary Share	$42.28M	181.37	-$173.42M	-$2.00	-45.04
BeOne Medicines	$3.81B	7.03	-$644.79M	-$3.72	-65.68

Which has more volatility and risk, VRNA or ONC?

Verona Pharma PLC American Depositary Share has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, BeOne Medicines has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500.

Do analysts recommend VRNA or ONC?

Verona Pharma PLC American Depositary Share presently has a consensus target price of $107.36, suggesting a potential upside of 19.19%. BeOne Medicines has a consensus target price of $320.67, suggesting a potential upside of 31.25%. Given BeOne Medicines' higher possible upside, analysts plainly believe BeOne Medicines is more favorable than Verona Pharma PLC American Depositary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verona Pharma PLC American Depositary Share	0 Sell rating(s)	0 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	3.00
BeOne Medicines	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders have more ownership in VRNA or ONC?

85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. Comparatively, 48.6% of BeOne Medicines shares are held by institutional investors. 4.8% of Verona Pharma PLC American Depositary Share shares are held by insiders. Comparatively, 6.6% of BeOne Medicines shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Verona Pharma PLC American Depositary Share beats BeOne Medicines on 8 of the 15 factors compared between the two stocks.